Product logins

Find logins to all Clarivate products below.


Interventional Cardiology Devices | Medtech 360 | Market Analysis | China | 2016

The recent economic downturn in China will have only limited impact on the Chinese market for IC devices, which will experience robust growth through 2024, driven primarily by the rising prevalence of CAD among the Chinese population and the introduction of more advanced diagnostic and treatment technology.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in China across a 10-year period.

Related Medtech Insights Reports

Report
Neurovascular Devices – Market Insights – Asia Pacific
The Asia Pacific neurovascular device market will grow moderately through the forecast period, driven by rising procedure volumes, anticipated product launches, and increasing affordability of…
Report
Deep Venous Disease Treatment Devices – Market Insights – Global
The uptake of innovative, higher-priced powered thrombectomy devices and their increasing adoption for treating PE—supported by favorable clinical data—will drive strong growth in the global…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – United States
The US EP mapping and ablation device market will experience strong growth through 2035, driven by the rapid expansion of AF ablation procedures, particularly PFA devices, and the approval of…